Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 71.4%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 28.6%High 0 · 0%

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Global state: relapse ‐ medium term ‐ not measured · patients with SCHIZOPHRENIA AND CANNABIS USE

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

General functioning ‐ no clinically important change in general functioning · patients with SCHIZOPHRENIA AND CANNABIS USE

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Adverse effects: no clinically important adverse effects ‐ medium term ‐ not measured · patients with SCHIZOPHRENIA AND CANNABIS USE

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Leaving the study early ‐ medium term ‐ not reported · patients with SCHIZOPHRENIA AND CANNABIS USE

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Satisfaction with treatment ‐ medium term ‐ not measured · patients with SCHIZOPHRENIA AND CANNABIS USE

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Cannabis use · patients with SCHIZOPHRENIA AND CANNABIS USE

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT… showed no clear difference in behaviour: Cannabis use: Used cannabis in last 4 weeks ‐ medium term… compared with NON‐SPECIFIC PSYCOEDUCTION (moderate certainty).

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
RR 1.04 [0.62, 1.74]
1 study · 47 participants
Moderate

CANNABIS REDUCTION: PSYCHOLOGICAL THERAPY (SPECIFICALLY ABOUT CANNABIS AND PSYCHOSIS) vs NON‐SPECIFIC PSYCOEDUCTION

Mental state · patients with SCHIZOPHRENIA AND CANNABIS USE

1 finding from 1 review

Cannabis and schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 47 participants
Moderate